Skip to main content
Premium Trial:

Request an Annual Quote

Jackson Laboratory Wins $3.4M NHGRI Grant to Study Workplace Genomic Testing

NEW YORK — The Jackson Laboratory has been awarded a $3.4 million grant from the National Human Genome Research Institute to study the ethical, legal, and social implications (ELSI) of workplace genomic testing in the US.

With the four-year grant, Jackson Laboratory researchers will lead an interdisciplinary team of experts from across the country to evaluate the employee health benefits of workplace genetic testing offered by employers and conducted by third-party companies.

The study will specifically focus on employers' perspectives on workplace genomic testing by analyzing the prevalence and distribution of such testing among US companies and through interviews with executives from companies that are either offering testing or have declined to do so. It will also examine employees' views on and responses to workplace genomic testing through surveys of both genetic test takers and those who have decided against such testing.

The research will be led by Jackson Laboratory researcher Charles Lee in collaboration with investigators from the University of Michigan, Johns Hopkins University, and Thomas Jefferson Health, a Pennsylvania-based healthcare system that has provided genetic testing to over 10,000 of its employees.

Also participating are researchers from Dartmouth University, Thomas Jefferson University, the University of Iowa, the University of Louisville, Case Western Reserve University, Vanderbilt University, the Maine Medical Center Research Institute, and Harvard Medical School.

"Workplace genomic testing raises substantial legal and policy concerns, including privacy of genetic information," Lee said in a statement. "Given that such testing is already occurring and that this testing will become even more prevalent in the future, there is an urgent need to understand its benefits and risks."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.